← Leaderboards
Karl D. Kieburtz
University Of Rochester
$41,391,578
Attributed
$47,155,032
Total exposure
14
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $7.7M · FY2005–22$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$47,155,032 · 14
By mechanism
U01$24,229,275 · 1
UL1$10,726,422 · 1
U10$6,983,768 · 1
R01$1,581,853 · 2
KL2$1,251,534 · 1
P50$912,814 · 1
Top collaborators
- Nancy M Bennett6 shared
- Martin S Zand6 shared
Most similar at University Of Rochester
Same institution · by research overlap
- Robert C Griggs$26,725,330
- Lan Wei-Lapierre$2,515,283
- Lynne E Maquat$35,060,198
- Roman Jeno Giger$6,971,296
- John Haynes Werren$3,872,856
Others in their field
Top investigators on “Clinical Trials”
- Lawrence Corey · Fred Hutchinson Cancer Center$824,102,536
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$622,583,125
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,008,718
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$504,273,077
Research focus
Clinical TrialsResearch PersonnelCollaborationsClinical ResearchTrainingBaseUniversitiesProgramsSafetyDesignAffectParkinson DiseaseUnited States National Institutes Of HealthDisease ProgressionProtocols DocumentationResearch InfrastructurePharmaceutical PreparationsHuman ResourcesMeasurableCommunitiesFosteringHuman SubjectAdultPilot Projects
Grant awards (52)
Research Project 1 will develop in silico models that predict PD progression and inform clinical trial design$177,303
P50 · FY2022 · NS · contact PI
Research Project 1 will develop in silico models that predict PD progression and inform clinical trial design$177,303
P50 · FY2021 · NS · contact PI
Research Project 1 will develop in silico models that predict PD progression and inform clinical trial design$172,081
P50 · FY2020 · NS · contact PI
Research Project 1 will develop in silico models that predict PD progression and inform clinical trial design$113,904
P50 · FY2019 · NS · contact PI
Research Project 1 will develop in silico models that predict PD progression and inform clinical trial design$272,223
P50 · FY2018 · NS · contact PI
The University of Rochester's Clinical and Translational Science Institute$3,674,728
UL1 · FY2015 · TR · contact PI
The University of Rochester Clinical and Translational Science Institute$411,264
KL2 · FY2015 · TR · contact PI
The University of Rochester Clinical and Translational Science Institute$236,848
TL1 · FY2015 · TR · contact PI
The University of Rochester's Clinical and Translational Science Institute$3,672,756
UL1 · FY2014 · TR · contact PI
Neuroprotection Studies in PD: A Coordinating Center.$1,739,290
U01 · FY2014 · NS · contact PI
The University of Rochester Clinical and Translational Science Institute$420,135
KL2 · FY2014 · TR · contact PI
The University of Rochester Clinical and Translational Science Institute$229,450
TL1 · FY2014 · TR · contact PI
The University of Rochester's Clinical and Translational Science Institute$3,378,938
UL1 · FY2013 · TR · contact PI
Neuroprotection Studies in PD: A Coordinating Center.$2,299,995
U01 · FY2013 · NS · contact PI
Data Coordination and Biostatistics Center for the NORDIC Network$1,213,826
U10 · FY2013 · EY · contact PI
The University of Rochester Clinical and Translational Science Institute$420,135
KL2 · FY2013 · TR · contact PI
The University of Rochester Clinical and Translational Science Institute$227,053
TL1 · FY2013 · TR · contact PI
U.S. India Collaborative Partnership in Parkinson Disease (CPPD)$186,366
R21 · FY2013 · NS · contact PI
Supplemental Funding to the NET PD Studies$1,011,241
U01 · FY2012 · NS · contact PI
Data Coordination and Biostatistics Center for the NORDIC Network$994,726
U10 · FY2012 · EY · contact PI
Neuroprotection Studies in PD: A Coordinating Center$540,132
U01 · FY2012 · NS · contact PI
Neuroprotection Studies in PD: A Coordinating Center$2,321,905
U01 · FY2011 · NS · contact PI
Data Coordination and Biostatistics Center for the NORDIC Network$1,151,816
U10 · FY2011 · EY · contact PI
U.S. India Collaborative Partnership in Parkinson Disease (CPPD)$231,750
R21 · FY2011 · NS · contact PI
Neuroprotection Studies in PD: A Coordinating Center$2,533,926
U01 · FY2010 · NS · contact PI
Data Coordination and Biostatistics Center for the NORDIC Network$1,331,473
U10 · FY2010 · EY · contact PI
Neuroprotection Studies in PD: A Coordinating Center$533,001
U01 · FY2010 · NS · contact PI
Neuroprotection Studies in PD: A Coordinating Center$2,388,219
U01 · FY2009 · NS · contact PI
Data Coordination and Biostatistics Center for the NORDIC Network$1,591,927
U10 · FY2009 · EY · contact PI
Data Coordination and Biostatistics Center for the NORDIC Network$700,000
U10 · FY2009 · EY · contact PI
Neuroprotection Studies in PD: A Coordinating Center$56,780
U01 · FY2009 · NS · contact PI
Neuroprotection Studies in PD: A Coordinating Center$2,100,369
U01 · FY2008 · NS · contact PI
Neuroprotection Studies in PD: A Coordinating Center$2,085,990
U01 · FY2007 · NS · contact PI
Neuroprotection Studies in PD: A Coordinating Center$1,315,041
U01 · FY2005 · NS
Neuroprotection Studies in PD: A Coordinating Center$78,000
U01 · FY2005 · NS
Neuroprotection Studies in PD: A Coordinating Center$1,315,191
U01 · FY2004 · NS
Neuroprotection Studies in PD: A Coordinating Center$1,347,154
U01 · FY2003 · NS
MIDCAREER INVESTIGATOR AWARD--PATIENT ORIENTED RESEARCH$63,516
K24 · FY2003 · NS
Neuroprotection Studies in PD: A Coordinating Center$1,325,710
U01 · FY2002 · NS
MIDCAREER INVESTIGATOR AWARD--PATIENT ORIENTED RESEARCH$62,802
K24 · FY2002 · NS
Neuroprotection Studies in PD: A Coordinating Center$1,237,331
U01 · FY2001 · NS
AMITRIPTYLINE AND MEXILITINE FOR PAINFUL NEUROPATHY IN HIV INFECTION$140,288
R01 · FY2001 · NS
MIDCAREER INVESTIGATOR AWARD--PATIENT ORIENTED RESEARCH$62,110
K24 · FY2001 · NS
SELEGILINE TRANSDERMAL SYS IN HIV COGNITIVE IMPAIRMENT$19,613
M01 · FY2001 · RR
TOLERABILITY AND SAFETY STUDY OF LEXIPAFANT IN HIV DEMENTIA$19,613
M01 · FY2001 · RR
TREATMENT OF PERSISTENT WEAKNESS IN HYPOKALEMIC PARALYSIS WITH MINOXIDIL$19,613
M01 · FY2001 · RR
NEUROPSYCHIATRIC MANIFESTATIONS OF HIV INFECTION--NATURAL HISTORY$19,613
M01 · FY2001 · RR
COENZYME Q10 AND REMACEMIDE--EVALUATION IN HD$1,167,974
R01 · FY2000 · NS
AMITRIPTYLINE AND MEXILITINE FOR PAINFUL NEUROPATHY IN HIV INFECTION$273,591
R01 · FY2000 · NS
MIDCAREER INVESTIGATOR AWARD--PATIENT ORIENTED RESEARCH$61,437
K24 · FY2000 · NS
SELEGILINE TRANSDERMAL SYS IN HIV COGNITIVE IMPAIRMENT$14,791
M01 · FY2000 · RR
TOLERABILITY AND SAFETY STUDY OF LEXIPAFANT IN HIV DEMENTIA$14,791
M01 · FY2000 · RR